For patients who have undiagnosed cancer, a months-long delay due to new prior a...
It's difficult for chemotherapy treatments to cross the blood-brain barrier. In ...
A panel of independent advisers to the FDA narrowly voted 8 to 6 to recommend ac...
Science for America brings researchers and technologists together to get outside...
The U.S. Senate health committee passed a package of bills aimed at speeding gen...
As I celebrate my fourth Mother’s Day, I’m reflecting on how I can reclaim time ...
We're live-blogging today's FDA advisory panel on Sarepta’s gene therapy for Duc...
It's difficult for chemotherapy treatments to cross the blood-brain barrier. In ...
Though a rulemaking may seem wonky, it will affect the lives of untold numbers o...
SFJ will file the biologics licence application for bentracimab to the US Food a...
The partners will work on public health research into diseases of national impor...
BB-1701 is currently in Phase I/II clinical trials in the US and China for HER-2...
An in vivo study in mice failed to show the same success as previous in vitro te...
The FDA mandated sponsors to update their prescription stimulants to raise aware...
New and updated data from the Phase I/II RUBY trial in sickle cell disease will ...
The new drug candidate is expected to reduce the death rate of blood cancer pati...
